Region Vaermland

Futó vizsgálatok

• Még nem toboroz

  Long-term outcomes and safety of repeated rituximab treatment in psychotic disorders – RITS-LONG

  2026-525324-26-00· 2. fázis· Forrás

• Toboroz

  The HIt HArd and hiT Early in Multiple Sclerosis Trial

  NCT07517185· 2. fázis· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Forrás

• Toboroz

  A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer.

  2024-511182-10-01· 4. fázis· Forrás

• Toboroz

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  NCT06742723· 3. fázis· Forrás

• Toboroz

  Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)

  2023-506998-35-00· 3. fázis· Forrás

• Toboroz

  Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

  NCT06488482· 3. fázis· Forrás

• Toboroz

  Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)

  2023-508398-10-00· 4. fázis· Forrás

• Toboroz

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  NCT06463587· 3. fázis· Forrás

• Toboroz

  SACK

  2022-501600-10-00· 3. fázis· Forrás

• Fut, nem toboroz

  Ixekizumab Diabetes Intervention Trial (I-DIT)

  NCT04589325· 2. fázis· Forrás

• Toboroz

  Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

  NCT04910802· 4. fázis· Forrás

• Fut, nem toboroz

  NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

  NCT04335669· 3. fázis· Forrás

• Toboroz

  ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

  NCT03903835· 3. fázis· Forrás

• Toboroz

  Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

  NCT02901184· 3. fázis· Forrás

• Fut, nem toboroz

  Adjuvant Low Dose Aspirin in Colorectal Cancer

  NCT02647099· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Krónikus vesebetegség3 toboroz
• Magas vérnyomás2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Glioblasztóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Méhnyakrák1 toboroz
• Melanóma1 toboroz
• Myasthenia gravis1 toboroz
• Pitvarfibrilláció1 toboroz
• Prosztatarák1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Skizofrénia1 toboroz
• Szívelégtelenség1 toboroz
• Vastagbélrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Fut, nem toboroz

  A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults

  NCT05622201· 2. fázis· Forrás

• Lezárult

  SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes

  NCT03982381· 4. fázis· Forrás

• Lezárult

  This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

  NCT03599245· 3. fázis· Forrás